162 related articles for article (PubMed ID: 20621035)
1. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
[TBL] [Abstract][Full Text] [Related]
2. The association between dietary vitamin K intake and serum undercarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype.
Nimptsch K; Nieters A; Hailer S; Wolfram G; Linseisen J
Br J Nutr; 2009 Jun; 101(12):1812-20. PubMed ID: 19025725
[TBL] [Abstract][Full Text] [Related]
3. Association between Vitamin K Epoxide Reductase (VKORC1) -1639G>A Polymorphism and Osteoporosis in Postmenopausal Women.
Kutluturk F; Inanir A; Rustemoglu A; Kaya SU; Demir AK; Dursun G; Yigit S
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):281-286. PubMed ID: 29437025
[TBL] [Abstract][Full Text] [Related]
4. VKORC1 common variation and bone mineral density in the Third National Health and Nutrition Examination Survey.
Crawford DC; Brown-Gentry K; Rieder MJ
PLoS One; 2010 Dec; 5(12):e15088. PubMed ID: 21179439
[TBL] [Abstract][Full Text] [Related]
5. Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status.
Crosier MD; Peter I; Booth SL; Bennett G; Dawson-Hughes B; Ordovas JM
J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):112-9. PubMed ID: 19436136
[TBL] [Abstract][Full Text] [Related]
6. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.
Nimptsch K; Rohrmann S; Nieters A; Linseisen J
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):49-56. PubMed ID: 19124480
[TBL] [Abstract][Full Text] [Related]
7. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection).
Wang Y; Zhang W; Zhang Y; Yang Y; Sun L; Hu S; Chen J; Zhang C; Zheng Y; Zhen Y; Sun K; Fu C; Yang T; Wang J; Sun J; Wu H; Glasgow WC; Hui R
Circulation; 2006 Mar; 113(12):1615-21. PubMed ID: 16549638
[TBL] [Abstract][Full Text] [Related]
8. Lack of Association Between Type 2 Diabetes and the 3673G / A and 9041G / A Gene Variants of Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1).
Ozbayer C; Kurt H; Nur Kebapci M; Turgut Cosan D; Colak E; Veysi Gunes H; Degirmenci I
Int J Vitam Nutr Res; 2016 Jun; 86(3-4):133-139. PubMed ID: 29469681
[TBL] [Abstract][Full Text] [Related]
9. Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness.
Fodor D; Bondor C; Albu A; Popp R; Pop IV; Poanta L
Indian J Med Res; 2013 Apr; 137(4):734-41. PubMed ID: 23703341
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
[TBL] [Abstract][Full Text] [Related]
11. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
12. The c.-1639G>A polymorphism of the VKORC1 gene in Serbian population: retrospective study of the variability in response to oral anticoagulant therapy.
Kovac MK; Maslac AR; Rakicevic LB; Radojkovic DP
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):558-63. PubMed ID: 20581661
[TBL] [Abstract][Full Text] [Related]
13. Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.
Turgut Cosan D; Yazıcı HU; Colak E; Soyocak A; Degirmenci I; Kurt H; Birdane A; Colak E; Gunes HV
Genet Test Mol Biomarkers; 2017 May; 21(5):292-297. PubMed ID: 28281786
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variation in VKORC1 and Risk for Osteoporosis.
He J; Xie H; Yan C; Sun Y; Xu Z; Zhang X
Arch Med Res; 2021 Feb; 52(2):211-216. PubMed ID: 33234259
[TBL] [Abstract][Full Text] [Related]
15. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
Loriot MA; Beaune P
Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
[TBL] [Abstract][Full Text] [Related]
16. VKORC1 and the vitamin K cycle.
Garcia AA; Reitsma PH
Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
[TBL] [Abstract][Full Text] [Related]
18. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.
Shyu HY; Fong CS; Fu YP; Shieh JC; Yin JH; Chang CY; Wang HW; Cheng CW
Clin Chim Acta; 2010 Jun; 411(11-12):840-5. PubMed ID: 20193673
[TBL] [Abstract][Full Text] [Related]
19. VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.
Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J
Eur J Clin Pharmacol; 2013 Mar; 69(3):467-75. PubMed ID: 22864379
[TBL] [Abstract][Full Text] [Related]
20. VKORC1 polymorphisms in Amerindian populations of Brazil.
Perini JA; Petzl-Erler ML; Tsuneto LT; Suarez-Kurtz G
Pharmacogenomics; 2008 Nov; 9(11):1623-9. PubMed ID: 19018718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
